267 related articles for article (PubMed ID: 35158967)
21. Pharmacological targeting the ATR-CHK1-WEE1 axis involves balancing cell growth stimulation and apoptosis.
Mak JP; Man WY; Ma HT; Poon RY
Oncotarget; 2014 Nov; 5(21):10546-57. PubMed ID: 25301733
[TBL] [Abstract][Full Text] [Related]
22. Caffeine inhibits checkpoint responses without inhibiting the ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) protein kinases.
Cortez D
J Biol Chem; 2003 Sep; 278(39):37139-45. PubMed ID: 12847089
[TBL] [Abstract][Full Text] [Related]
23. Importance of DNA damage checkpoints in the pathogenesis of human cancers.
Poehlmann A; Roessner A
Pathol Res Pract; 2010 Sep; 206(9):591-601. PubMed ID: 20674189
[TBL] [Abstract][Full Text] [Related]
24. ATM regulates ATR chromatin loading in response to DNA double-strand breaks.
Cuadrado M; Martinez-Pastor B; Murga M; Toledo LI; Gutierrez-Martinez P; Lopez E; Fernandez-Capetillo O
J Exp Med; 2006 Feb; 203(2):297-303. PubMed ID: 16461339
[TBL] [Abstract][Full Text] [Related]
25. Imatinib inhibits inactivation of the ATM/ATR signaling pathway and recovery from adriamycin/doxorubicin-induced DNA damage checkpoint arrest.
Morii M; Fukumoto Y; Kubota S; Yamaguchi N; Nakayama Y; Yamaguchi N
Cell Biol Int; 2015 Aug; 39(8):923-32. PubMed ID: 25790472
[TBL] [Abstract][Full Text] [Related]
26. ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells.
Ronco C; Martin AR; Demange L; Benhida R
Medchemcomm; 2017 Feb; 8(2):295-319. PubMed ID: 30108746
[TBL] [Abstract][Full Text] [Related]
27. The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints.
Neumann J; Boerries M; Köhler R; Giaisi M; Krammer PH; Busch H; Li-Weber M
Int J Cancer; 2014 Apr; 134(8):1991-2002. PubMed ID: 24150948
[TBL] [Abstract][Full Text] [Related]
28. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.
Xiao Z; Xue J; Sowin TJ; Zhang H
Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of checkpoint kinase 1 abrogates G2/M checkpoint activation and promotes apoptosis under heat stress.
Furusawa Y; Iizumi T; Fujiwara Y; Zhao QL; Tabuchi Y; Nomura T; Kondo T
Apoptosis; 2012 Jan; 17(1):102-12. PubMed ID: 22080164
[TBL] [Abstract][Full Text] [Related]
30. MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells.
Wang WJ; Wu SP; Liu JB; Shi YS; Huang X; Zhang QB; Yao KT
Cancer Res; 2013 Feb; 73(3):1219-31. PubMed ID: 23269272
[TBL] [Abstract][Full Text] [Related]
31. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.
Reinhardt HC; Yaffe MB
Curr Opin Cell Biol; 2009 Apr; 21(2):245-55. PubMed ID: 19230643
[TBL] [Abstract][Full Text] [Related]
32. ATR signaling cooperates with ATM in the mechanism of low dose hypersensitivity induced by carbon ion beam.
Xue L; Furusawa Y; Yu D
DNA Repair (Amst); 2015 Oct; 34():1-8. PubMed ID: 26246317
[TBL] [Abstract][Full Text] [Related]
33. Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside.
Sriramulu S; Thoidingjam S; Brown SL; Siddiqui F; Movsas B; Nyati S
Biomed Pharmacother; 2023 Feb; 158():114126. PubMed ID: 36521246
[TBL] [Abstract][Full Text] [Related]
34. DNA damage checkpoint control in cells exposed to ionizing radiation.
Iliakis G; Wang Y; Guan J; Wang H
Oncogene; 2003 Sep; 22(37):5834-47. PubMed ID: 12947390
[TBL] [Abstract][Full Text] [Related]
35. ATR dependent activation of Chk2.
Wang XQ; Redpath JL; Fan ST; Stanbridge EJ
J Cell Physiol; 2006 Sep; 208(3):613-9. PubMed ID: 16741947
[TBL] [Abstract][Full Text] [Related]
36. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
[TBL] [Abstract][Full Text] [Related]
37. DNA damage checkpoints in mammals.
Niida H; Nakanishi M
Mutagenesis; 2006 Jan; 21(1):3-9. PubMed ID: 16314342
[TBL] [Abstract][Full Text] [Related]
38. Targeting chk2 kinase: molecular interaction maps and therapeutic rationale.
Pommier Y; Sordet O; Rao VA; Zhang H; Kohn KW
Curr Pharm Des; 2005; 11(22):2855-72. PubMed ID: 16101442
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of checkpoint kinase 1 is associated with the increased radiosensitivity of glioblastoma stem-like cells.
Wu J; Lai G; Wan F; Xiao Z; Zeng L; Wang X; Ye F; Lei T
Tohoku J Exp Med; 2012 Apr; 226(4):267-74. PubMed ID: 22481303
[TBL] [Abstract][Full Text] [Related]
40. XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer.
Wang W; Guo M; Xia X; Zhang C; Zeng Y; Wu S
Biomed Res Int; 2017; 2017():5718968. PubMed ID: 29082250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
